✦ LIBER ✦

Phase II and Phase III Trials: Docetaxel/Irinotecan versus Docetaxel/Cisplatin in Advanced Non–Small-Cell Lung Cancer (WJTOG 9803)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised phase II study of docetaxel/c

✍ Yamamoto, N; Fukuoka, M; Negoro, S-I; Nakagawa, K; Saito, H; Matsui, K; Kawahara 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

Phase I study of cisplatin, docetaxel an

✍ Kiura, K; Ueoka, H; Eguchi, K; Segawa, Y; Takigawa, N; Kamei, H; Shibayama, T; H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

P-47 Phase II study of cisplatin and iri

✍ Charoentrum, Chaiyut; Thongprasert, Sumitra; Chewasakulyong, Busyamas; Euathrong 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Docetaxel Versus Docetaxel/Cisplatin in

✍ V. Georgoulias; A.G. Pallis; C. Kourousis; A. Alexopoulos; A. Ardavanis; A. Agel 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 150 KB

Randomized phase II study of docetaxel p

✍ Saito, H; Yamamoto, N; Negoro, S; Nakagawa, K; Matsui, K; Kawahara, M; Takada, Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Docetaxel plus cisplatin versus docetaxe

✍ V. Georgoulias; E. Papadakis; A. Alexopoulos; E. Stavrinidis; E. Bania; A. Rapti 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB